J. R. Bogner

Clinical Outcome of HIV-Infected Patients with Discordant Virological and Immunological Response to Antiretroviral Therapy

Alexander Zoufaly, Matthias an der Heiden, Christian Kollan et al. · The Journal of Infectious Diseases · 2010 · 71 citations · Full text

Infection With Human Immunodeficiency Virus-1 Increases Expression of Vascular Endothelial Cell Growth Factor in T Cells: Implications for Acquired Immunodeficiency Syndrome-Associated Vasculopathy

Gudrun Ascherl, Christine Hohenadl, Octavian Schatz et al. · Blood · 1999 · 69 citations

Class II (DR) antigen expression on CD8+ lymphocyte subsets in acquired immune deficiency syndrome (AIDS)

H.W.L. Ziegler-Heitbrock, Daniel Stachel, T. Schlunk et al. · Journal of Clinical Immunology · 1988 · 36 citations

Primary Immunodeficiency, Class Ii, Autoimmune Disease +11

Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial

Pedro Cahn, Richard Kaplan, Paul E. Sax et al. · The Lancet HIV · 2017 · 35 citations · Full text

Treatment And Prevention, Antiviral Drug Development, Clinical Trials +9

Liposomal doxorubicin in the treatment of AIDS-associated Kaposi's sarcoma: clinical, histological and cell biological evaluation

Michael Stürzl, C Zietz, B. Eisenburg et al. · Research in Virology · 1994 · 33 citations

Aids-associated Kaposi, Immunodeficiencies, Pathology +5